The best Australian shares to watch
Commonwealth Bank, Telstra, CSL, Wesfarmers and BHP could be the best Australian shares to watch next quarter. These are not recommendations, simply some of the largest Australian companies across a range of sectors.
What's on this page?
The Australian economy enters Q4 on uncertain terms. While the financial situation seems to be improving, the Reserve Bank has increased the cash rate to 4.35% and CPI inflation remained above the target range at 4.3% in November.
Australian inflation therefore remains the core problem and increases in the cost of borrowing will continue to put pressure across the economy. Key potential pressure points include overleveraged mortgage borrowers, the potential for bad bank loans, and the slowdown of the Chinese economy — which is by far Australia’s largest two-way trading partner.
But Q4 may be an excellent time to invest in Australian shares. The market tends to be forward-looking, and the expectation is that inflation will continue to fall while the cash rate is close to its peak.
Of course, inflation globally has proved far stickier than many analysts had expected, so investors may wish to be careful with their assumptions. Inflation, like a weed, has a habit of coming back if monetary policy is loosened before completely under control.
But with sunnier times perhaps ahead, here’s five ASX stocks to consider for Q2.
The best Australian shares to watch
These are not recommendations, simply some of the largest Australian companies across a range of sectors.
Commonwealth Bank is Australia’s largest bank — and together with National Australia Bank, Westpac, and ANZ — constitutes one of the ‘Big Four’ of the ASX 200. It generates most of its revenue from lending to homebuyers through mortgages, and also to businesses.
But the bank also offers multiple insurance products, including for homes and cars, and operates the largest online broker in Australia, CommSec. It also operates in New Zealand as Auckland Savings Bank.
Commonwealth — which manages 25%, or $2 trillion of Australia’s mortgages — posted a record $10.16 billion cash profit in the last financial year but has also been forced to put aside $1.47 billion more for potential bad loans given ‘ongoing cost of living pressures and rising interest rates.’ For context, CEO Matt Comyn considers that while the number of borrowers struggling remains below pre-pandemic levels, ‘these figures will rise.’
Of course, with inflation now falling the bank may be poised for another excellent quarter.
Telstra is the largest ASX telecommunications company by market share and engages in building telecommunications networks and markets-related products and services. In Australia, it provides 18.8 million retail mobile services, 3.8 million retail fixed bundles and standalone data services, and 960,000 retail fixed standalone voice services.
ASX telecoms stocks can be attractive in uncertain economic times; while better growth can be found elsewhere, mobile and broadband services are very defensive — customers usually consider connectivity a necessity rather than as a luxury.
In FY23 results, Telstra saw revenue rise by 9.2% year -over-year to $23.2 billion, and the company boasted a profit margin of 8.3% — up by 0.4 percentage points compared to FY22.
CSL is Australia’s largest biotech company and has been operating for over a century. With the combined capability of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever — making it a popular choice for differentiated ASX investors.
CSL boasts a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies. The company operates across three sectors; rare and serious diseases; influenza vaccines; and iron deficiency and nephrology. Again, the size of the company can be attractive given the expense of clinical trials for new treatments, as is the multi-focused business
The company now provides lifesaving products to patients in more than 100 countries, and it employs 30,000 people. At its AGM meeting, CEO Dr Paul McKenzie noted that the company has ‘have a number of late-stage R&D programs that are approaching fruition. These are potentially high value medicines that will help drive the improvement in our margin.’ And in full-year results, total revenue rose by 26% to US$13.3 billion.
Further, for FY24, the company is expecting revenue growth of between 9% and 11%.
Wesfarmers is a hugely diversified retail operator which owns some of Australia’s most famous retail brands. Its undertakings cover sectors including home improvement and outdoor living, apparel and general merchandise, office supplies, health, beauty and wellbeing, chemicals, energy and fertilisers, and industrial and safety products.
FY23 saw Wesfarmers increase net profit after tax by 4.8% to $2.46 billion, with free cash flow of $3.6 billion. And most impressively, it saw a return on equity of 31.4%.
As one of the country’s largest employers, Wesfarmers boasts a brand portfolio that includes Bunnings, Priceline Pharmacy, Kmart, Officeworks, and catch.com.au. Accordingly, it’s a popular share with retail investors as many are more comfortable investing in a company they already ‘know’ at the coal face.
BHP is the largest mining company in the world based on market capitalisation, and also usually the largest company on the ASX 200, accounting for circa 10% of the country’s share market.
The corporation generates over half of its profits from selling iron ore, predominantly to China, but it also sells copper, nickel, potash, and coal.
The company is a global operator with mines across Australia, the United States, Canada, Chile, Peru, Brazil, and Columbia; this variation across jurisdictions and minerals can be compelling for investors who value diversification. And despite the threat of slowing Chinese economic activity, BHP is actively engaging in asset acquisition, including recently buying up copper junior Oz Minerals.
Past performance is not an indicator of future returns.
How to invest or trade in Australian shares with us
Take your position on over 13,000 local and international shares via CFDs or share trading – all at your fingertips on our award-winning platform.*
Winner of ‘Best Multi-Platform Provider’ at ADVFN International Finance Awards 2022
IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.
The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.
Please see important Research Disclaimer.
Seize a share opportunity today
Go long or short on thousands of international stocks.
- Increase your market exposure with leverage
- Get spreads from just 0.1% on major global shares
- Trade CFDs straight into order books with direct market access